DISCO
About DISCO
DISCO Pharmaceuticals is a company that specializes in developing a comprehensive cartography of the cancer cell surface to identify new druggable targets. They use their proprietary surfaceome discovery technology to unlock the entire cancer cell surface at scale, enabling the identification of protein communities and unlocking comprehensive target information that standard proteomics, genome, or transcriptome sequencing cannot provide.
Recent News
Legal Tech Vendors Roll Out Wave of Announcements Ahead of Legalweek; News From DISCO, Advocacy, iManage, Monjur, Reveal and ChronoTracer and ALIGN
Who Knows? – a New Deep House Banger From The Static Dive and Kilo House
The Latest Orange Rag Product Table – Link Here
Asian Shares Surge, Led by Records in Japan, S Korea, as Markets Regain Momentum
TransPerfect Legal Teams with Merlin Search to Fuse AI eDiscovery and Search
Maja Malou Lyse on Representing Denmark at the 61st Venice Biennale
